A prognostic model incorporating T/N stage, tumor markers, and systemic immune-inflammation index achieved 3-year survival prediction AUCs of 0.897 in training and 0.861 in external validation cohorts of 410 patients under 50. (Transl Cancer Res)
Nomogram predicts survival in early-onset colorectal cancer using routine lab markers
The CRC Digest